These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1287208

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L.
    Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M, Liz-Lestón J, Lado-Abeal J.
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 8. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Hsu MI, Liou TH, Liang SJ, Su HW, Wu CH, Hsu CS.
    Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 11. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 13. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR, Sowter MC, Carter MA, Knox BS, Gunn AJ.
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [Abstract] [Full Text] [Related]

  • 14. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A.
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [Abstract] [Full Text] [Related]

  • 15. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
    Shterev AD, Dokumov SI.
    Endocrinologie; 1982 Nov; 20(3):203-7. PubMed ID: 6815773
    [Abstract] [Full Text] [Related]

  • 16. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
    Su HW, Chen CM, Chou SY, Liang SJ, Hsu CS, Hsu MI.
    Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [Abstract] [Full Text] [Related]

  • 18. Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.
    Hauzman EE, Fancsovits P, Murber A, Rabe T, Strowitzki T, Papp Z, Urbancsek J.
    J Assist Reprod Genet; 2006 Mar; 23(3):141-7. PubMed ID: 16758344
    [Abstract] [Full Text] [Related]

  • 19. Characterization of pulsatile secretion of gonadotropin and prolactin in women with normal menstrual cycle, secondary amenorrhea and polycystic ovary syndrome (PCOS).
    Lin KC, Lee JN.
    Kaohsiung J Med Sci; 1998 Feb; 14(2):61-7. PubMed ID: 9542361
    [Abstract] [Full Text] [Related]

  • 20. Reproducibility of luteinizing hormone hypersecretion in different phases of the menstrual cycle in polycystic ovary syndrome.
    Iwasa T, Matsuzaki T, Murakami M, Shimizu F, Kuwahara A, Yasui T, Irahara M.
    J Obstet Gynaecol Res; 2009 Jun; 35(3):514-9. PubMed ID: 19527392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.